Stuart Walter Peltz - 04 Jan 2022 Form 4 Insider Report for PTC THERAPEUTICS, INC. (PTCT)

Role
Chief Executive Officer, Director
Signature
/s/ Avraham S. Adler, attorney-in-fact
Issuer symbol
PTCT
Transactions as of
04 Jan 2022
Net transactions value
-$15,559
Form type
4
Filing time
06 Jan 2022, 15:08:59 UTC
Previous filing
11 Jun 2021
Next filing
11 Jan 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PTCT Common Stock Sale $15,559 -378 -1.6% $41.16 22,834 04 Jan 2022 By Spouse F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares automatically sold pursuant to an irrevocable sell to cover election to satisfy tax withholding obligations in connection with the vesting of 1,313 shares of restricted stock from a January 3, 2018 grant of 5,250 shares of restricted stock.
F2 Includes 206 shares of common stock acquired under the Issuer's employee stock purchase plan for the period ending June 30, 2021 and 285 shares of common stock acquired under the Issuer's employee stock purchase plan for the period ending December 31, 2021.